We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microscope Lenses Include Higher Numerical Aperture Objectives

By Labmedica staff writers
Posted on 04 Jun 2008
A manufacturer of high precision ultraviolet (UV) optical systems has expanded its range of UV lenses to include a high numerical aperture (NA) UV microscope objective with a numerical aperture of 0.90. More...
This complements the current high NA UV line that includes 0.75 NA and 0.50 NA objectives.

The features of high NA UV objectives are the diffraction limited design, the air spacing for high power applications, and the achromatic design. Therefore, the new line of UV lenses offers a higher level of performance compared with standard microscope objectives. The NA UV micro objective provides 0.28-micron spot imaging at a wavelength of 248 nm and 0.41-micron spot imaging at a wavelength of 365 nm. The effective focal length is 5.5 mm and the field of view is 100 microns.

The lenses were designed by Special Optics, Inc. (Wharton, New Jersey, USA), a company that supplies precision optical assemblies for high-technology applications, and serves the medical, defense, security, semiconductor, and commercial original equipment manufacturer (OEM) markets.

Special Optics is a Navitar (Rochester, NY, USA) company. Navitar supplies optics, optomechanical sub-assemblies, and optoelectronic solutions for microscopy, automation, nanotechnology, and other systems. It has offices and subsidiaries in the United States, Japan, Germany, China, Israel, and the United Kingdom.


Related Links:
Navitar
Special Optics

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
STI Test
RIDA GENE STI Mycoplasma Panel
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.